Takeda Pharmaceuticals Appeals $885M Antitrust Verdict, Citing Rebates and Subsidies in Massachusetts Case
Takeda Pharmaceuticals is embroiled in a dispute over whether an $885 million antitrust verdict issued by a Massachusetts federal jury should be reduced due to rebates and subsidies that allegedly offset the costs borne by a class of health plans. The verdict came after allegations that Takeda conspired to delay the entry of generic competition…